Our results indicate that a strategy based on the antagonism of fetuin-A may be a novel therapeutic approach to the treatment of acetaminophen-induced acute liver failure.
58 subjects were included.Fetuin A was studied in patients undergoing open abdominal surgery and in a subset with acute liver failure.Blood and liver specimens were sampled.NAFLD was histologically evaluated.